These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 18772723)

  • 1. Retention and retention of effect of topical formulations in dry eye subjects.
    Paugh JR; Nguyen AL; Huang P; Hwang JS
    Optom Vis Sci; 2008 Sep; 85(9):873-9. PubMed ID: 18772723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Precorneal residence time of artificial tears measured in dry eye subjects.
    Paugh JR; Nguyen AL; Ketelson HA; Christensen MT; Meadows DL
    Optom Vis Sci; 2008 Aug; 85(8):725-31. PubMed ID: 18677236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visual effect and residence time of artificial tears in dry eye subjects.
    Hall JQ; Ridder WH; Nguyen AL; Paugh JR
    Optom Vis Sci; 2011 Jul; 88(7):872-80. PubMed ID: 21532516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel method to evaluate residence time in humans using a nonpenetrating fluorescent tracer.
    Meadows DL; Paugh JR; Joshi A; Mordaunt J
    Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1032-9. PubMed ID: 11923244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized double-masked study of 0.05% cyclosporine ophthalmic emulsion in the treatment of meibomian gland dysfunction.
    Prabhasawat P; Tesavibul N; Mahawong W
    Cornea; 2012 Dec; 31(12):1386-93. PubMed ID: 23135530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical performance of a mid-viscosity artificial tear for dry eye treatment.
    Simmons PA; Vehige JG
    Cornea; 2007 Apr; 26(3):294-302. PubMed ID: 17413956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of sodium hyaluronate eyedrops in the treatment of dry eye.
    Johnson ME; Murphy PJ; Boulton M
    Graefes Arch Clin Exp Ophthalmol; 2006 Jan; 244(1):109-12. PubMed ID: 15983814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of diquafosol ophthalmic solution in patients with dry eye syndrome: a Japanese phase 2 clinical trial.
    Matsumoto Y; Ohashi Y; Watanabe H; Tsubota K;
    Ophthalmology; 2012 Oct; 119(10):1954-60. PubMed ID: 22739038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the clinical course of dry eye syndrome.
    Horwath-Winter J; Berghold A; Schmut O; Floegel I; Solhdju V; Bodner E; Schwantzer G; Haller-Schober EM
    Arch Ophthalmol; 2003 Oct; 121(10):1364-8. PubMed ID: 14557170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of three different liposomal eye sprays on ocular comfort and tear film.
    Pult H; Gill F; Riede-Pult BH
    Cont Lens Anterior Eye; 2012 Oct; 35(5):203-7; quiz 243-4. PubMed ID: 22705318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of the low blink rate in rabbits on topical drug penetration.
    Maurice D
    J Ocul Pharmacol Ther; 1995; 11(3):297-304. PubMed ID: 8590262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel formulation of glycerin 1% artificial tears extends tear film break-up time compared with Systane lubricant eye drops.
    Gensheimer WG; Kleinman DM; Gonzalez MO; Sobti D; Cooper ER; Smits G; Loxley A; Mitchnick M; Aquavella JV
    J Ocul Pharmacol Ther; 2012 Oct; 28(5):473-8. PubMed ID: 22554205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorophotometry as a diagnostic tool for the evaluation of dry eye disease.
    Fahim MM; Haji S; Koonapareddy CV; Fan VC; Asbell PA
    BMC Ophthalmol; 2006 May; 6():20. PubMed ID: 16729882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An open-label, investigator-masked, crossover study of the ocular drying effects of two antihistamines, topical epinastine and systemic loratadine, in adult volunteers with seasonal allergic conjunctivitis.
    Ousler GW; Workman DA; Torkildsen GL
    Clin Ther; 2007 Apr; 29(4):611-6. PubMed ID: 17617284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tear breakup dynamics: a technique for quantifying tear film instability.
    Begley CG; Himebaugh N; Renner D; Liu H; Chalmers R; Simpson T; Varikooty J
    Optom Vis Sci; 2006 Jan; 83(1):15-21. PubMed ID: 16432468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbomer and sodium hyaluronate eyedrops for moderate dry eye treatment.
    Johnson ME; Murphy PJ; Boulton M
    Optom Vis Sci; 2008 Aug; 85(8):750-7. PubMed ID: 18677239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of tear fluorescein clearance and Schirmer test scores with ocular irritation symptoms.
    Afonso AA; Monroy D; Stern ME; Feuer WJ; Tseng SC; Pflugfelder SC
    Ophthalmology; 1999 Apr; 106(4):803-10. PubMed ID: 10201606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pilot, prospective, randomized, double-masked, placebo-controlled clinical trial of an omega-3 supplement for dry eye.
    Wojtowicz JC; Butovich I; Uchiyama E; Aronowicz J; Agee S; McCulley JP
    Cornea; 2011 Mar; 30(3):308-14. PubMed ID: 21045648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trehalose versus hyaluronan or cellulose in eyedrops for the treatment of dry eye.
    Matsuo T
    Jpn J Ophthalmol; 2004; 48(4):321-7. PubMed ID: 15295655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between tear-meniscus parameters and tear-film breakup.
    Golding TR; Bruce AS; Mainstone JC
    Cornea; 1997 Nov; 16(6):649-61. PubMed ID: 9395875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.